RecommendationOffer pad tests to men with LUTS having specialist assessment only if the degree of urinary incontinence needs to be measured.
Relative values of different outcomesThe GDG considered that an improvement in symptoms was the most important outcome.
Trade off between clinical benefits and harmsThe test has no side effects or harms but takes time. The GDG recommended that this test should not be routinely offered because of the absence of evidence and they were unsure of the benefit it offered.
Economic considerationsThe costs associated with a pad test are those associated with the cost of pads; incurred by the patient using the time to do the test, and those associated with the healthcare professionals who explain and supervise the test, and then deal with the pads and patient afterwards. There is a trade-off between the cost of performing a pad test and the information it could provide. This test is likely to add useful information only in special cases.
Quality of evidenceNo clinical or economic evidence was found.
Other considerationsThe GDG have not stated a specific degree of incontinence that would require this test as male incontinence is uncommon and any amount leaked would be considered to be significant.

From: 4, Diagnosis

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.